1.
Alavi-Moghaddam M, Sistanizad M, Haghighi M, Sabaghian T, Gholami Chaboki B, Soroureddin Z. Efficacy and safety of sofosbuvir in the treatment of SARS-CoV-2: an open label phase II trial. Front Emerg Med. 2023;7(1):e7.